Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04121754 · ClinicalTrials.gov registry record · NA
Post-Stroke Walking Speed and Community Ambulation Conversion Study
A NA study, sponsored by MedRhythms.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT04121754: Completed NA study, sponsored by MedRhythms.
NCT04121754 is a NA study that has completed, run by MedRhythms. The registered enrollment target is 87 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04121754, a NA study, has completed, sponsored by MedRhythms.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
The purpose of this randomized, controlled study is to collect performance data on the ability of an investigational device designed to digitally deliver Rhythmic Auditory Stimulation to improve walking speed in people who suffered a stroke greater than six (6) months in the past and who are limited in mobility outside the home. The primary outcomes will be the mean change in walking speed (meters per second) and mean percent change in walking speed as determined by a 10-meter Walk Test after five weeks of intervention and compared between groups.
Primary Outcome
Mean change in gait speed (meters per second) measured by the 10-Meter Walk Test compared between groups.
Interventions
- DEVICE MR-001
- OTHER Active Walking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2019-09-17 |
| Est. Completion | 2022-02-11 |
| Phase | NA |
What the finished NCT04121754 record still lists
NCT04121754 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which MR-001 is the first listed.
NCT04121754 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04121754 about?
NCT04121754 is a clinical study titled "Post-Stroke Walking Speed and Community Ambulation Conversion Study". The purpose of this randomized, controlled study is to collect performance data on the ability of an investigational device designed to digitally deliver Rhythmic Auditory Stimulation to improve walking speed in people who suffered a stroke greater than six (6) months in the past and who are limited...
What is the current status of trial NCT04121754?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2019-09-17. Estimated completion is 2022-02-11.
What interventions are being tested in trial NCT04121754?
The interventions under investigation include: MR-001 (DEVICE), Active Walking (OTHER).
Who is sponsoring clinical trial NCT04121754?
This trial is sponsored by MedRhythms, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04121754's enrollment target sits among peer trials
87 974th of 2000 higher than 1,025 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI